ctDNA for Tracking Minimal Residual Disease in Colon Cancer ctDNA for Tracking Minimal Residual Disease in Colon Cancer

Find out about the potential role of plasma circulating-tumor DNA in determining minimal residual disease in patients with localized colon cancer.Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news